Real-world comparison of cabazitaxel vs. 177-lutetium-PSMA radioligand therapy in metastatic castration resistant prostate cancer.

被引：0
|
作者：
Wenzel, Mike
Koll, Florestan
Hoeh, Benedikt
Humke, Clara
Siech, Carolin
Mader, Nicolai
Groener, Daniel
Steuber, Thomas
Graefen, Markus
Maurer, Tobias
Brandts, Christian H.
Banek, Severine
Chun, Felix
Mandel, Philipp
机构：
[1] Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Urol, Frankfurt, Germany
[3] Univ Hosp Frankfurt, Dept Nucl Med, Frankfurt, Germany
[4] Goethe Univ Frankfurt, Dept Nucl Med, Frankfurt, Germany
[5] Univ Hosp Hamburg Eppendorf, Martini Klin Prostate Canc Ctr, Hamburg, Germany
[6] Prostate Canc Ctr Hamburg, Martini Clin, Hamburg, Germany
[7] Goethe Univ Frankfurt, Frankfurt, Germany
[8] Goethe Univ Frankfurt, Dept Urol, Frankfurt, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.70
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world data for predictors of PSA response to Lu177-PSMA-617 in metastatic castration resistant prostate cancer
    Hassoun, Rebecca
    Tann, Mark
    Sims, Justin
    Auxier, Ashleigh
    Althouse, Sandra K.
    King, Jennifer
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Efficacy and safety of Lutetium-177 PSMA radioligand therapy versus Docetaxel in metastatic castration resistant prostate cancer - preliminary results of a randomized controlled trial
    Satapathy, Swayamjeet
    Mittal, Bhagwant
    Sood, Ashwani
    Bhattacharya, Anish
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [23] Investigating Combination Therapy: The Role of Lutetium-177 PSMA-617 Radioligand Therapy and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer
    Kinikoglu, Oguzcan
    Oven, Bala Basak
    Celik, Serkan
    Selcuk, Nalan Alan
    Beydagi, Gamze
    Akcay, Kaan
    Kabasakal, Levent
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (16)
  • [24] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [25] 177Lu-PSMA-I&T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer:FirstClinical trialin Asia
    Bu, Ting
    Zhang, Pengjun
    Zang, Shiming
    Zhang, Lulu
    Wang, Feng
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [26] Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
    Rahbar, Kambiz
    Bode, Axel
    Weckesser, Matthias
    Avramovic, Nemanja
    Claesener, Michael
    Stegger, Lars
    Boegemann, Martin
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 522 - 528
  • [27] Treatment efficacy and safety of 177Lu-PSMA Radioligand Therapy in Octogenarians with metastatic castration-resistant prostate cancer
    Langbein, T.
    Retz, M.
    D'Alessandria, C.
    Grigorascu, S.
    Hansen, K.
    Wester, H.
    Gschwend, J.
    Weber, W.
    Eiber, M.
    Tauber, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S132 - S133
  • [28] 177Lu-EB-PSMA Radioligand Therapy with Escalating Doses in Patients with Metastatic Castration-Resistant Prostate Cancer
    Zang, Jie
    Liu, Qingxing
    Sui, Huimin
    Wang, Rongxi
    Jacobson, Orit
    Fan, Xinrong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (12) : 1772 - 1778
  • [29] Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Bal, Chandrashekhar
    Sahoo, Ranjit Kumar
    Damle, Nishikant Avinash
    Tripathi, Madhavi
    Seth, Amlesh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 19 - 31
  • [30] 177Lu-EB-PSMA radioligand therapy with escalating doses in patients with metastatic castration-resistant prostate cancer
    Zang, Jie
    Liu, Qingxing
    Sui, Huimin
    Wang, Rongxi
    Jacobson, Orit
    Zhu, Zhaohui
    Chen, Xiaoyuan
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345